The global sunitinib malate market is anticipated to gain growth at a significant CAGR in the forecast period. Sunitinib was the first cancer treatment to be licenced for two indications at the same time, renal cell carcinoma and imatinib-resistant gastrointestinal stromal tumour (GIST).

The global sunitinib malate market is mainly driven by technological development and the increasing prevalence of pancreatic cancer. New prospects for the sunitinib malate market are estimated to emerge as pancreatic cancer awareness grows in rising countries such as China, India, and others.  On other hand, the global sunitinib malate market is obstructed by higher research and development costs as well as high Sutent costs.

The global sunitinib malate market for pancreatic cancer has grown steadily over the years, and this trend is projected to continue in the years ahead. This is mostly due to the rising usage of pharmacological therapy for the treatment of pancreatic cancer in the market. Patients with pancreatic neuroendocrine tumours (pNET) are classified into three stages, localised, progressed, and distant. As this type of tumour produces almost no symptoms, it is difficult to diagnose it in its early stages, the number of patients suffering from distant pNET is larger that is boosting the market growth.

Market Coverage

    • The market number available for – 2021-2027

    • The base year – 2020 

    • The forecast period is from 2021 to 2027

    • Segment Covered- 

o By Product Type 

o By Application

o By End-User

    • Regions Covered 

o North America

o Europe

o Asia-Pacific

o Rest of the World

    • Competitive Landscape: Abbvie, Abbott, West-Ward Pharms, Actavis Labs Fl Inc., Sun Pharm Inds, Mylan, Mayne Pharma, 

Key questions addressed by the report

    • What is the market growth rate?

    • Which segment and region dominate the market in the base year?

    • Which segment and region will project the fastest growth in the market?

    • How has COVID-19 impacted the market?

o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

    • Who is the leader in the market?

    • How players are addressing challenges to sustain growth?

    • Where is the investment opportunity?

Global Sunitinib Malate Market by Segments 

By Product type 

    • Tablet

    • Capsule

    • Suspension

By Application

    • Pancreatic Neuroendocrine Tumors

    • Advanced Kidney Cancer

    • Gastrointestinal stromal tumour (GIST)

    • others.

By End-User 

    • Hospital Pharmacy

    • Retail Pharmacy

    • Clinics

    • Ecommerce

    • Others 

Global Sunitinib Malate Market by Region

North America

    • US

    • Canada

Europe

    • UK

    • Germany

    • Italy

    • Spain

    • France

    • Rest of Europe 

Asia-Pacific

    • China

    • India

    • Japan

    • Rest of Asia-Pacific

Rest of the World

    • Latin America 

    • Middle East & Africa